IPO Watch | ASX Upcoming Floats, Live Floats, & Listing Scorecards

View Original

IXC and NXR added.

First up with have biopharmaceutical provider Invex Therapeutics (IXC) who are developing “treatments for neurological conditions derived from or involving raised intracranial pressure”. The prosectus delves a little deeper, but you may need a thesaurus handy.

The 25M shares on offer will be priced at 40 cents each as the company looks to raise 10M, a successful completion will see Market Cap at 20M. Get all the details in the prospectus here.

If you’re looking for something a little more traditional then Nemex Resources may be more your style. “Nemex is a junior exploration company with a conditional right to acquire mineral exploration projects prospective for gold and base metals located in Western Australia”.

20 cents will buy you one of over 25M shares on offer with a full raise seeing around 5M flowing in, market cap will be a bit over 10M on completion. Prospectus can be found here.